AIM ImmunoTech Inc (AIM)
0.2446
-0.01
(-2.08%)
USD |
NYAM |
Nov 07, 16:00
0.2577
+0.01
(+5.36%)
After-Hours: 20:00
AIM ImmunoTech Revenue (Annual): 0.202M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.202M |
| December 31, 2022 | 0.141M |
| December 31, 2021 | 0.135M |
| December 31, 2020 | 0.163M |
| December 31, 2019 | 0.14M |
| December 31, 2018 | 0.367M |
| December 31, 2017 | 0.437M |
| December 31, 2016 | 0.092M |
| December 31, 2015 | 0.133M |
| December 31, 2014 | 0.197M |
| December 31, 2013 | 0.15M |
| December 31, 2012 | 0.213M |
| December 31, 2011 | 0.161M |
| December 31, 2010 | 0.135M |
| December 31, 2009 | 0.111M |
| Date | Value |
|---|---|
| December 31, 2008 | 0.265M |
| December 31, 2007 | 1.059M |
| December 31, 2006 | 0.933M |
| December 31, 2005 | 1.083M |
| December 31, 2004 | 1.229M |
| December 31, 2003 | 0.657M |
| December 31, 2002 | 0.341M |
| December 31, 2001 | 0.39M |
| December 31, 2000 | 0.788M |
| December 31, 1999 | 0.678M |
| December 31, 1998 | 0.401M |
| December 31, 1997 | 0.30M |
| December 31, 1996 | 0.10M |
| December 31, 1995 | 3.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.135M
Minimum
2021
0.202M
Maximum
2023
0.1562M
Average
0.141M
Median
2022
Revenue (Annual) Benchmarks
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 65.49M |
| Electromed Inc | 54.72M |
| Xtant Medical Holdings Inc | 91.30M |
| Armata Pharmaceuticals Inc | -- |